Banner image

Centrul de Oncologie Sf Nectarie SRL


The St. Nectarie Oncology Centre in Craiova is a private inpatient healthcare facility dedicated to the care of oncological patients through integrated medical services, delivered in a modern, safe environment oriented towards patient needs. Through its experienced and expert medical team, clinical research activities, and integrated service structure, the centre consolidates its role as a regional centre of excellence in oncology.

Located in Craiova at 109 Caracal Street, the centre provides oncological medical services including day hospitalisation, continuous hospitalisation, investigations, treatments, and services related to oncological medical care. The centre operates within an integrated medical platform comprising: a building dedicated to radiotherapy, equipped with 2 linear accelerators; a building with 107 beds for day and continuous oncological hospitalisation; and a building dedicated entirely to the recovery of oncological patients.

The mission of the St. Nectarie Oncology Centre is to support oncological patients through rapid access to high-quality medical services, modern treatments, close monitoring, and multidisciplinary support. The centre aims to provide patients with a well-organised medical pathway, with emphasis on patient safety, respect for human dignity, quality of medical care, and constant communication between the patient, family, and medical team.

The St. Nectarie Oncology Centre in Craiova has been conducting clinical research since 2014, running Phase II and Phase III clinical trials with therapeutic benefit for patients. Over the years, the centre has supported the conduct of over 200 clinical trials, building a dedicated internal team for research activities. The accumulated experience has enabled the development of long-term relationships with sponsors, research organisations, and technology transfer centres, delivering fast, accurate, and high-quality results validated in EMEA and FDA inspections and multiple audits. The facilities of the St. Nectarie Oncology Centre meet the specific criteria required for conducting Phase 1/bioequivalence clinical trials.

Objectives


  • Ensuring rapid access to high-quality oncological medical services through the integrated medical platform (radiotherapy, day and continuous hospitalisation, recovery).
  • Providing a well-organised medical pathway centred on patient safety, respect for human dignity, quality of medical care, and constant communication between the patient, family, and medical team.
  • Conducting high-quality clinical research through Phase I–III clinical trials validated by EMEA and FDA, contributing to the advancement of oncological treatments.
Resources